Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_4f59d61d9a32422593c3515a44620ac5 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Christine Learned, BA |e author |
| 700 | 1 | 0 | |a Sara Alsukait, MBBS |e author |
| 700 | 1 | 0 | |a Sandhya Deverapalli, MD, MBBS |e author |
| 700 | 1 | 0 | |a Erika Elliott, MD |e author |
| 700 | 1 | 0 | |a Katherine Moody, MD |e author |
| 700 | 1 | 0 | |a Jeffrey Sobell, MD |e author |
| 700 | 1 | 0 | |a Nellie Konnikov, MD |e author |
| 700 | 1 | 0 | |a Melissa Ortega, PharmD |e author |
| 700 | 1 | 0 | |a David Rosmarin, MD |e author |
| 245 | 0 | 0 | |a Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021 |
| 260 | |b Elsevier, |c 2022-06-01T00:00:00Z. | ||
| 500 | |a 2666-3287 | ||
| 500 | |a 10.1016/j.jdin.2022.03.010 | ||
| 546 | |a EN | ||
| 690 | |a adverse events | ||
| 690 | |a drug reactions | ||
| 690 | |a drug-induced psoriasis | ||
| 690 | |a immunodermatology | ||
| 690 | |a psoriasis | ||
| 690 | |a Dermatology | ||
| 690 | |a RL1-803 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n JAAD International, Vol 7, Iss , Pp 144-145 (2022) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2666328722000396 | |
| 787 | 0 | |n https://doaj.org/toc/2666-3287 | |
| 856 | 4 | 1 | |u https://doaj.org/article/4f59d61d9a32422593c3515a44620ac5 |z Connect to this object online. |